Excited to share our publication in @ScienceAdvances for #PVP-037 titled “From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation” https://t.co/2p4eyoDzb2
That's a wrap for the Olympic Games Paris 2024 🤩
Our Team Sanofi dazzled us by winning 4 medals! Also THANK YOU to the 1,000+ Sanofians who volunteered during the Olympics 🫶
We're ready to cheer on our Team Sanofi at the Paris 2024 #Paralympics Games!
#Olympics#Paris2024
Overall, PVP-037's discovery and development has been guided by Drs. @levy_o and @David_J_Dowling, who continue to advance the area of Precision Vaccines. https://t.co/CxB8tWNOL0
Excited to share our publication in @ScienceAdvances for #PVP-037 titled “From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation” https://t.co/2p4eyoDzb2
Additionally, PVP-037 based-formulations are also being utilized for an adjuvanted vaccine against fentanyl overdose in the Opioid Boston Project https://t.co/RqkvcNPo3c
“From hit to vial” – We did something special with the discovery of our exciting new TLR7/8 agonist adjuvant family - essentially condensing a full vaccine development pipeline lifecycle into a single manuscript – Today, we are happy to introduce PVP-037. @PrecVaccines@ScienceAdvances https://t.co/Sec9XIOhay
"from hit to vial": Human in vitro modeling enables discovery and development of an imidazopyrimidine small-molecule TLR7/8 adjuvant @ScienceAdvances@sdh33ru@levy_o@David_J_Dowling
https://t.co/4vNdP1ec7k
New article in @CommsBio led by @PrecVaccines researchers Drs @SoumikBarman3, @levy_o & @David_J_Dowling characterizes adjuvant specific innate immune responses across life span using cutting-edge CyTOF technology and computational approaches. #CyTOF
https://t.co/qdwuV20N0g
Chandrayaan-3 Mission update:
The spacecraft's health is normal.
The first orbit-raising maneuver (Earthbound firing-1) is successfully performed at ISTRAC/ISRO, Bengaluru.
Spacecraft is now in 41762 km x 173 km orbit.